BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scoffone VC, Chiarelli LR, Trespidi G, Mentasti M, Riccardi G, Buroni S. Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches. Front Microbiol 2017;8:1592. [PMID: 28878751 DOI: 10.3389/fmicb.2017.01592] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 16.2] [Reference Citation Analysis]
Number Citing Articles
1 Dagenais RV, Quon BS, Franciosi AN. Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report. Respiratory Medicine Case Reports 2022. [DOI: 10.1016/j.rmcr.2022.101772] [Reference Citation Analysis]
2 Ciuca IM, Dediu M, Popin D, Pop LL, Tamas LA, Pilut CN, Almajan Guta B, Popa ZL. Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review. Children 2022;9:1258. [DOI: 10.3390/children9081258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sun Q, Yan J, Liao X, Wang C, Wang C, Jiang G, Dong L, Wang F, Huang H, Wang G, Pan J. Trends and Species Diversity of Non-tuberculous Mycobacteria Isolated From Respiratiroy Samples in Northern China, 2014–2021. Front Public Health 2022;10:923968. [DOI: 10.3389/fpubh.2022.923968] [Reference Citation Analysis]
4 Davis CM, Ruest MK, Cole JH, Dennis JJ. The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1. Viruses 2022;14:938. [PMID: 35632679 DOI: 10.3390/v14050938] [Reference Citation Analysis]
5 Paszti S, Vitale A, Liu Y, Braunwalder R, Kalawong R, Biner O, Pessi G, Eberl L. Identification of Key Factors for Anoxic Survival of B. cenocepacia H111. Int J Mol Sci 2022;23:4560. [PMID: 35562951 DOI: 10.3390/ijms23094560] [Reference Citation Analysis]
6 Bové M, Coenye T. The anti-virulence activity of the non-mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution. Microbiology (Reading) 2022;168. [PMID: 35358034 DOI: 10.1099/mic.0.001170] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Rezene S, Yao G, Le T, Burrowes B, Gonzalez C, Liu M, Gill J. Complete Genome Sequence of Burkholderia cenocepacia Phage Paku. Microbiol Resour Announc 2022;:e0122021. [PMID: 35343779 DOI: 10.1128/mra.01220-21] [Reference Citation Analysis]
8 Grove A. Extracytoplasmic Function Sigma Factors Governing Production of the Primary Siderophores in Pathogenic Burkholderia Species. Front Microbiol 2022;13:851011. [PMID: 35283809 DOI: 10.3389/fmicb.2022.851011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chin JH, Samian MR, Normi YM. Characterization of polyhydroxyalkanoate production capacity, composition and weight synthesized by Burkholderia cepacia JC-1 from various carbon sources. Heliyon 2022;8:e09174. [PMID: 35368536 DOI: 10.1016/j.heliyon.2022.e09174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Peyclit L, Baron SA, Hadjadj L, Rolain J. In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria. Antibiotics 2022;11:291. [DOI: 10.3390/antibiotics11030291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Badr A, Eltobgy M, Krause K, Hamilton K, Estfanous S, Daily KP, Abu Khweek A, Hegazi A, Anne MNK, Carafice C, Robledo-avila F, Saqr Y, Zhang X, Bonfield TL, Gavrilin MA, Partida-sanchez S, Seveau S, Cormet-boyaka E, Amer AO. CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages. Front Cell Infect Microbiol 2022;12:819554. [DOI: 10.3389/fcimb.2022.819554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 O'Leary MK, Sundaram V, LiPuma JJ, Dörr T, Westblade LF, Alabi CA. Mechanism of Action and Resistance Evasion of an Antimicrobial Oligomer against Multidrug-Resistant Gram-Negative Bacteria. ACS Appl Bio Mater 2022. [PMID: 35167257 DOI: 10.1021/acsabm.1c01217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kline A, Zerbe C. Infections in primary immunodeficiency. Allergic and Immunologic Diseases 2022. [DOI: 10.1016/b978-0-323-95061-9.00028-x] [Reference Citation Analysis]
14 Booty LM, Bryant CE. Gasdermin D and Beyond - Gasdermin-mediated Pyroptosis in Bacterial Infections. J Mol Biol 2021;:167409. [PMID: 34929200 DOI: 10.1016/j.jmb.2021.167409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Seixas AMM, Sousa SA, Feliciano JR, Gomes SC, Ferreira MR, Moreira LM, Leitão JH. A Polyclonal Antibody Raised against the Burkholderia cenocepacia OmpA-like Protein BCAL2645 Impairs the Bacterium Adhesion and Invasion of Human Epithelial Cells In Vitro. Biomedicines 2021;9:1788. [PMID: 34944603 DOI: 10.3390/biomedicines9121788] [Reference Citation Analysis]
16 Maydaniuk D, Wu B, Truong D, Liyanage SH, Hogan AM, Yap ZL, Yan M, Cardona ST. New Auranofin Analogs with Antibacterial Properties against Burkholderia Clinical Isolates. Antibiotics (Basel) 2021;10:1443. [PMID: 34943654 DOI: 10.3390/antibiotics10121443] [Reference Citation Analysis]
17 Torres DA, Seth-Smith HMB, Joosse N, Lang C, Dubuis O, Nüesch-Inderbinen M, Hinic V, Egli A. Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms. BMC Microbiol 2021;21:321. [PMID: 34798825 DOI: 10.1186/s12866-021-02388-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Jaiyesimi OA, McAvoy AC, Fogg DN, Garg N. Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors. Sci Rep 2021;11:21419. [PMID: 34725378 DOI: 10.1038/s41598-021-00421-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Flores-Vega VR, Vargas-Roldán SY, Lezana-Fernández JL, Lascurain R, Santos-Preciado JI, Rosales-Reyes R. Bacterial Subversion of Autophagy in Cystic Fibrosis. Front Cell Infect Microbiol 2021;11:760922. [PMID: 34692569 DOI: 10.3389/fcimb.2021.760922] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Nepravishta R, Monaco S, Distefano M, Rizzo R, Cescutti P, Angulo J. Multifrequency STD NMR Unveils the Interactions of Antibiotics With Burkholderia multivorans Biofilm Exopolysaccharide. Front Mol Biosci 2021;8:727980. [PMID: 34604306 DOI: 10.3389/fmolb.2021.727980] [Reference Citation Analysis]
21 Maydaniuk D, Wu B, Truong D, Liyanage SH, Hogan AM, Yap ZL, Yan M, Cardona ST. New auranofin analogs with antibacterial properties against Burkholderia clinical isolates.. [DOI: 10.1101/2021.09.10.459877] [Reference Citation Analysis]
22 Hogan AM, Jeffers KR, Palacios A, Cardona ST. Improved Dynamic Range of a Rhamnose-Inducible Promoter for Gene Expression in Burkholderia spp. Appl Environ Microbiol 2021;87:e0064721. [PMID: 34190606 DOI: 10.1128/AEM.00647-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Somprasong N, Yi J, Hall CM, Webb JR, Sahl JW, Wagner DM, Keim P, Currie BJ, Schweizer HP. Conservation of Resistance-Nodulation-Cell Division Efflux Pump-Mediated Antibiotic Resistance in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Species. Antimicrob Agents Chemother 2021;65:e0092021. [PMID: 34181473 DOI: 10.1128/AAC.00920-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Harrington NE, Littler JL, Harrison F. Transcriptome analysis of Pseudomonas aeruginosa biofilm infection in an ex vivo pig model of the cystic fibrosis lung.. [DOI: 10.1101/2021.07.23.453509] [Reference Citation Analysis]
25 Scoffone VC, Trespidi G, Barbieri G, Irudal S, Perrin E, Buroni S. Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens. Antibiotics (Basel) 2021;10:863. [PMID: 34356783 DOI: 10.3390/antibiotics10070863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
26 Diamond E, Hewlett K, Penumutchu S, Belenky A, Belenky P. Coffee Consumption Modulates Amoxicillin-Induced Dysbiosis in the Murine Gut Microbiome. Front Microbiol 2021;12:637282. [PMID: 34276581 DOI: 10.3389/fmicb.2021.637282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sousa SA, Seixas AMM, Marques JMM, Leitão JH. Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections. Vaccines (Basel) 2021;9:670. [PMID: 34207253 DOI: 10.3390/vaccines9060670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Aiyer A, Manoharan A, Paino D, Farrell J, Whiteley GS, Kriel FH, Glasbey TO, Manos J, Das T. Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy. Int J Antimicrob Agents 2021;58:106372. [PMID: 34116184 DOI: 10.1016/j.ijantimicag.2021.106372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Abd-Allah IM, El-Housseiny GS, Yahia IS, Aboshanab KM, Hassouna NA. Rekindling of a Masterful Precedent; Bacteriophage: Reappraisal and Future Pursuits. Front Cell Infect Microbiol 2021;11:635597. [PMID: 34136415 DOI: 10.3389/fcimb.2021.635597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Walpole GFW, Plumb JD, Chung D, Tang B, Boulay B, Osborne DG, Piotrowski JT, Catz SD, Billadeau DD, Grinstein S, Jaumouillé V. Inactivation of Rho GTPases by Burkholderia cenocepacia Induces a WASH-Mediated Actin Polymerization that Delays Phagosome Maturation. Cell Rep 2020;31:107721. [PMID: 32492429 DOI: 10.1016/j.celrep.2020.107721] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
31 Pimenta AI, Kilcoyne M, Bernardes N, Mil-Homens D, Joshi L, Fialho AM. Burkholderia cenocepacia BCAM2418-induced antibody inhibits bacterial adhesion, confers protection to infection and enables identification of host glycans as adhesin targets. Cell Microbiol 2021;23:e13340. [PMID: 33822465 DOI: 10.1111/cmi.13340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Marinelli F, Alifano P, Landini P, Visca P. Editorial: XXXIII SIMGBM Congress 2019 - Antimicrobials and Host-Pathogen Interactions. Front Microbiol 2021;12:672517. [PMID: 33897678 DOI: 10.3389/fmicb.2021.672517] [Reference Citation Analysis]
33 Altay O, Zhang C, Turkez H, Nielsen J, Uhlén M, Mardinoglu A. Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling. Metabolites 2021;11:221. [PMID: 33916474 DOI: 10.3390/metabo11040221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
34 Prothiwa M, Filz V, Oehler S, Böttcher T. Inhibiting quinolone biosynthesis of Burkholderia. Chem Sci 2021;12:6908-12. [PMID: 34123319 DOI: 10.1039/d0sc06167k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Grund ME, Soo JC, Cote CK, Berisio R, Lukomski S. Thinking Outside the Bug: Targeting Outer Membrane Proteins for Burkholderia Vaccines. Cells 2021;10:495. [PMID: 33668922 DOI: 10.3390/cells10030495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
36 Taher NM, Hvorecny KL, Burke CM, Gilman MSA, Heussler GE, Adolf-Bryfogle J, Bahl CD, O'Toole GA, Madden DR. Biochemical and structural characterization of two cif-like epoxide hydrolases from Burkholderia cenocepacia. Curr Res Struct Biol 2021;3:72-84. [PMID: 34235487 DOI: 10.1016/j.crstbi.2021.02.002] [Reference Citation Analysis]
37 Somprasong N, Hall CM, Webb JR, Sahl JW, Wagner DM, Keim P, Currie BJ, Schweizer HP. Burkholderia ubonensis High-Level Tetracycline Resistance Is Due to Efflux Pump Synergy Involving a Novel TetA(64) Resistance Determinant. Antimicrob Agents Chemother 2021;65:e01767-20. [PMID: 33318011 DOI: 10.1128/AAC.01767-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Papp-Wallace KM, Shapiro AB, Becka SA, Zeiser ET, LiPuma JJ, Lane DJ, Panchal RG, Mueller JP, O'Donnell JP, Miller AA. In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species. Antimicrob Agents Chemother 2021;65:e01930-20. [PMID: 33318017 DOI: 10.1128/AAC.01930-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Estfanous S, Krause K, Anne MNK, Eltobgy M, Caution K, Abu Khweek A, Hamilton K, Badr A, Daily K, Carafice C, Baetzhold D, Zhang X, Li T, Wen H, Gavrilin MA, Haffez H, Soror S, Amer AO. Gasdermin D restricts Burkholderia cenocepacia infection in vitro and in vivo. Sci Rep 2021;11:855. [PMID: 33441602 DOI: 10.1038/s41598-020-79201-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
40 Davis CM, McCutcheon JG, Dennis JJ. Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA01. Microorganisms 2021;9:152. [PMID: 33445453 DOI: 10.3390/microorganisms9010152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
41 Snell G, Smibert O, Tullis E. Burkholderia in Transplant: Important to Speciate and Important to Treat. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_22] [Reference Citation Analysis]
42 Wang G, Zarodkiewicz P, Valvano MA. Current Advances in Burkholderia Vaccines Development. Cells 2020;9:E2671. [PMID: 33322641 DOI: 10.3390/cells9122671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
43 Trespidi G, Scoffone VC, Barbieri G, Riccardi G, De Rossi E, Buroni S. Molecular Characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design. Antibiotics (Basel) 2020;9:E841. [PMID: 33255486 DOI: 10.3390/antibiotics9120841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ross BN, Thiriot JD, Wilson SM, Torres AG. Predicting toxins found in toxin-antitoxin systems with a role in host-induced Burkholderia pseudomallei persistence. Sci Rep 2020;10:16923. [PMID: 33037311 DOI: 10.1038/s41598-020-73887-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Sousa SA, Seixas AMM, Mandal M, Rodríguez-Ortega MJ, Leitão JH. Characterization of the Burkholderia cenocepacia J2315 Surface-Exposed Immunoproteome. Vaccines (Basel) 2020;8:E509. [PMID: 32899969 DOI: 10.3390/vaccines8030509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Adak T, Morales DL, Cook AJ, Grigg JC, Murphy MEP, Tanner ME. ArnD is a deformylase involved in polymyxin resistance. Chem Commun (Camb) 2020;56:6830-3. [PMID: 32432293 DOI: 10.1039/d0cc02241a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Fidalgo B, Bosch J, Cobo T, Ribera L, Casals C, Almela M. Bacteremia and intramniotic infection due to Burkholderia cenocepacea. Clin Microbiol Infect 2020;26:1564-5. [PMID: 32470570 DOI: 10.1016/j.cmi.2020.05.014] [Reference Citation Analysis]
48 Chiarelli LR, Scoffone VC, Trespidi G, Barbieri G, Riabova O, Monakhova N, Porta A, Manina G, Riccardi G, Makarov V, Buroni S. Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia. Front Microbiol 2020;11:562. [PMID: 32318042 DOI: 10.3389/fmicb.2020.00562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Scoffone VC, Barbieri G, Buroni S, Scarselli M, Pizza M, Rappuoli R, Riccardi G. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia. Trends in Microbiology 2020;28:315-26. [DOI: 10.1016/j.tim.2019.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
50 Gaglione R, Cesaro A, Dell'Olmo E, Di Girolamo R, Tartaglione L, Pizzo E, Arciello A. Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease. Int J Mol Sci 2020;21:E2049. [PMID: 32192076 DOI: 10.3390/ijms21062049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
51 Buroni S, Makarov V, Scoffone VC, Trespidi G, Riccardi G, Chiarelli LR. The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens. Eur J Med Chem 2020;190:112132. [PMID: 32066012 DOI: 10.1016/j.ejmech.2020.112132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
52 Sabet M, Griffith DC. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection. Antimicrob Agents Chemother 2020;64:e01988-19. [PMID: 31712215 DOI: 10.1128/AAC.01988-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Sánchez-Rodríguez R, González GM, Becerril-García MA, Treviño-Rangel RJ, Marcos-Vilchis A, González-Pedrajo B, Valvano MA, Andrade A. The BPtpA protein from Burkholderia cenocepacia belongs to a new subclass of low molecular weight protein tyrosine phosphatases. Arch Biochem Biophys 2020;681:108277. [PMID: 31978399 DOI: 10.1016/j.abb.2020.108277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ganesh PS, Vishnupriya S, Vadivelu J, Mariappan V, Vellasamy KM, Shankar EM. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors. Microbiol Immunol 2020;64:87-98. [PMID: 31769530 DOI: 10.1111/1348-0421.12762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
55 Bermeo R, Bernardi A, Varrot A. BC2L-C N-Terminal Lectin Domain Complexed with Histo Blood Group Oligosaccharides Provides New Structural Information. Molecules 2020;25:E248. [PMID: 31936166 DOI: 10.3390/molecules25020248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Snell G, Smibert O, Tullis E. Burkholderia in Transplant: Important to Speciate and Important to Treat. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_22-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Thompson R, Stephenson D, Sykes HE, Perry JD, Stanforth SP, Dean JR. Detection of β-alanyl aminopeptidase as a biomarker for Pseudomonas aeruginosa in the sputum of patients with cystic fibrosis using exogenous volatile organic compound evolution. RSC Adv 2020;10:10634-10645. [DOI: 10.1039/c9ra08386c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wallner A, King E, Ngonkeu ELM, Moulin L, Béna G. Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans. BMC Genomics 2019;20:803. [PMID: 31684866 DOI: 10.1186/s12864-019-6186-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
59 Costabile G, Provenzano R, Azzalin A, Scoffone VC, Chiarelli LR, Rondelli V, Grillo I, Zinn T, Lepioshkin A, Savina S, Miro A, Quaglia F, Makarov V, Coenye T, Brocca P, Riccardi G, Buroni S, Ungaro F. PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection. Nanomedicine 2020;23:102113. [PMID: 31669084 DOI: 10.1016/j.nano.2019.102113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
60 Sousa SA, Soares-Castro P, Seixas AMM, Feliciano JR, Balugas B, Barreto C, Pereira L, Santos PM, Leitão JH. New insights into the immunoproteome of B. cenocepacia J2315 using serum samples from cystic fibrosis patients. N Biotechnol 2020;54:62-70. [PMID: 31465856 DOI: 10.1016/j.nbt.2019.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Hassan AA, Coutinho CP, Sá-Correia I. Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection. Front Cell Infect Microbiol 2019;9:273. [PMID: 31417878 DOI: 10.3389/fcimb.2019.00273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
62 Fathy Mohamed Y, Scott NE, Molinaro A, Creuzenet C, Ortega X, Lertmemongkolchai G, Tunney MM, Green H, Jones AM, DeShazer D, Currie BJ, Foster LJ, Ingram R, De Castro C, Valvano MA. A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans. J Biol Chem 2019;294:13248-68. [PMID: 31350337 DOI: 10.1074/jbc.RA119.009671] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
63 Scoffone VC, Trespidi G, Chiarelli LR, Barbieri G, Buroni S. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens. Int J Mol Sci 2019;20:E1838. [PMID: 31013936 DOI: 10.3390/ijms20081838] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
64 Sass A, Slachmuylders L, Van Acker H, Vandenbussche I, Ostyn L, Bové M, Crabbé A, Chiarelli LR, Buroni S, Van Nieuwerburgh F, Abatih E, Coenye T. Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms. Antimicrob Agents Chemother 2019;63:e02092-18. [PMID: 30670425 DOI: 10.1128/AAC.02092-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
65 Behren S, Westerlind U. Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and Perspectives. Molecules 2019;24:E1004. [PMID: 30871155 DOI: 10.3390/molecules24061004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
66 Martínez-hidalgo P, Maymon M, Pule-meulenberg F, Hirsch AM. Engineering root microbiomes for healthier crops and soils using beneficial, environmentally safe bacteria. Can J Microbiol 2019;65:91-104. [DOI: 10.1139/cjm-2018-0315] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
67 Sabrin A, Gioe BW, Gupta A, Grove A. An EmrB multidrug efflux pump in Burkholderia thailandensis with unexpected roles in antibiotic resistance. J Biol Chem 2019;294:1891-903. [PMID: 30545940 DOI: 10.1074/jbc.RA118.006638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
68 Naguib MM, Valvano MA. Vitamin E Increases Antimicrobial Sensitivity by Inhibiting Bacterial Lipocalin Antibiotic Binding. mSphere 2018;3:e00564-18. [PMID: 30541778 DOI: 10.1128/mSphere.00564-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
69 Pita T, Feliciano JR, Leitão JH. Small Noncoding Regulatory RNAs from Pseudomonas aeruginosa and Burkholderia cepacia Complex. Int J Mol Sci 2018;19:E3759. [PMID: 30486355 DOI: 10.3390/ijms19123759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
70 Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST. Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ. Antimicrob Agents Chemother 2018;62:e01231-18. [PMID: 30297366 DOI: 10.1128/AAC.01231-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
71 Yu JE, Azar AE, Chong HJ, Jongco AM 3rd, Prince BT. Considerations in the Diagnosis of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc 2018;7:S6-S11. [PMID: 29746674 DOI: 10.1093/jpids/piy007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
72 Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS One 2018;13:e0203941. [PMID: 30273348 DOI: 10.1371/journal.pone.0203941] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
73 Goodlet KJ, Nailor MD, Omar A, Huang JL, LiPuma JJ, Walia R, Tokman S. Successful Lung Re-transplant in a Patient with Cepacia Syndrome due to Burkholderia ambifaria. J Cyst Fibros 2019;18:e1-4. [PMID: 30224331 DOI: 10.1016/j.jcf.2018.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
74 Sass A, Slachmuylders L, Acker HV, Vandenbussche I, Ostyn L, Crabbé A, Chiarelli L, Buroni S, Nieuwerburgh FV, Abatih E, Coenye T. Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate inBurkholderia cenocepaciabiofilms.. [DOI: 10.1101/409078] [Reference Citation Analysis]
75 Mariappan V, Thavagnanam S, Vellasamy KM, Teh CJS, Atiya N, Ponnampalavanar S, Vadivelu J. Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia. BMC Infect Dis 2018;18:455. [PMID: 30185168 DOI: 10.1186/s12879-018-3371-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Buroni S, Scoffone VC, Fumagalli M, Makarov V, Cagnone M, Trespidi G, De Rossi E, Forneris F, Riccardi G, Chiarelli LR. Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study. Front Pharmacol 2018;9:836. [PMID: 30108505 DOI: 10.3389/fphar.2018.00836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
77 Sousa SA, Seixas AMM, Leitão JH. Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Burkholderia cepacia Complex. Vaccines (Basel) 2018;6:E34. [PMID: 29890657 DOI: 10.3390/vaccines6020034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
78 Sass A, Everaert A, Van Acker H, Van den Driessche F, Coenye T. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics. Antimicrob Agents Chemother 2018;62:e02607-17. [PMID: 29439968 DOI: 10.1128/AAC.02607-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
79 Rosales-Reyes R, Sánchez-Gómez C, Ortiz-Navarrete V, Santos-Preciado JI. Burkholderia cenocepacia Induces Macropinocytosis to Enter Macrophages. Biomed Res Int 2018;2018:4271560. [PMID: 29850514 DOI: 10.1155/2018/4271560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]